Two humble pills for headache or fever are now raising alarm bells in laboratories from Adelaide to Geneva.
Long treated as harmless staples of the family medicine cabinet, ibuprofen and paracetamol are increasingly implicated in a threat that worries infectious‑disease experts far more than the next seasonal flu: the silent rise of antibiotic resistance.
From harmless helpers to global health concern
For decades, these drugs have been the first line of defence against everyday pain. Got a fever, a bad back, a throbbing tooth, or a nasty winter bug? In much of the world you can walk into a pharmacy and pick up ibuprofen or paracetamol without a prescription, often in large packs, and take them with little second thought.
They work. They are cheap. They feel safe. That combination has fuelled massive, routine consumption, especially in high‑income countries where access to medicines is broad and medical visits are short.
But new research suggests that, when swallowed alongside antibiotics, these familiar pills may help bacteria learn how to fight back. Not just against one antibiotic, but against several at once.
Behind the reassuring image of an everyday painkiller lies a subtle effect: it may be helping microbes get better at outsmarting our strongest drugs.
What an Australian lab saw in a petri dish
In 2025, researchers at the University of South Australia published work that jolted many infectious‑disease specialists. Their experiment focused on Escherichia coli, better known as E. coli, a bacterium that lives in our intestines and is a frequent cause of urinary‑tract and gut infections.
The team exposed E. coli to a common antibiotic, ciprofloxacin, either alone or in combination with an over‑the‑counter painkiller such as ibuprofen or paracetamol. Their goal was to see how quickly and in what way the bacterial population changed.
Bacteria exposed to ciprofloxacin alone did what evolution predicts: over time, some cells mutated and became more resistant to the drug. That part was no surprise. The shock came when an analgesic was added to the mix.
When painkillers were present, E. coli did not just become resistant more quickly to ciprofloxacin. The bacteria also showed increased resistance to other antibiotics they had never “seen”. The presence of an analgesic seemed to act like an amplifier, nudging the microbes into broader defences.
➡️ Abdominal fat after 60 : the easiest, most effective exercise you’re not doing
➡️ Meteorologists warn that February is set to begin with a rare Arctic atmospheric breakdown
➡️ The United States uncovers a “stealth gap” that could prove costly against China – and the Pentagon’s timeline alarms everyone
➡️ Before, my plants froze every winter – until I stopped throwing away this “green waste”
➡️ 16 photos of dogs with puppy souls who have no idea how big they are
➡️ Here Is How A Bay Leaf Can Make You Look Younger: Visible Effects In Just A Few Days
➡️ Meteorologists warn that an unusually early Arctic breakdown is forming in February, with atmospheric signals not seen in decades
➡️ Dividing a nation: Why millions cheer as billionaire tax dodgers fund public services, and millions more seethe at a system built on legal corruption
Combining a painkiller with an antibiotic pushed bacteria towards tougher, multi‑drug resistance, beyond what the antibiotic alone produced.
Why this matters outside the lab
This is not a niche scenario. Many people prescribed antibiotics for a urinary infection or a chest infection also take an analgesic for fever, muscle pain or headaches. In older patients and those with chronic illnesses, drug combinations are common, often involving several medications at once.
Today, that practice looks less benign. Each time an antibiotic course is accompanied by high and repeated doses of ibuprofen or paracetamol, the odds of creating harder‑to‑kill bacteria may increase, at least according to these early findings.
Antibiotic resistance: a crisis already under way
Antibiotic resistance is not a speculative problem waiting somewhere in the distant future. It is already claiming lives on a large scale. The World Health Organization estimates that antimicrobial resistance, which includes resistance to antibiotics, was directly linked to around 1.27 million deaths in 2019 alone.
When bacteria become resistant, routine treatments lose their punch. A simple urinary‑tract infection can spread to the kidneys and bloodstream. A common post‑surgery infection can turn into a medical emergency. Treatments that once took a few days and a basic prescription start requiring hospitalisation, intravenous drugs, or in some cases, last‑ditch antibiotics with serious side‑effects.
If widely used painkillers are nudging bacteria along this path, even slightly, the public‑health consequences scale rapidly. These tablets are taken by millions every day, in every continent.
Who is most at risk?
Certain groups face higher stakes:
- Older adults: They often live with multiple conditions, take several drugs, and are frequently prescribed antibiotics, creating many chances for risky combinations.
- People with chronic illnesses: Those undergoing cancer treatment, dialysis or immunosuppressive therapy are vulnerable to infections and depend heavily on antibiotics.
- Hospitalised patients: In hospitals, drug use is dense. Mixing pain management and aggressive antibiotic regimens is common, and resistant bacteria can circulate easily.
- Children: Kids frequently receive antibiotics and painkillers for ear infections, sore throats and fevers, though their overall dosing is more tightly controlled.
The more often antibiotics and common painkillers are taken together, the more chances we give bacteria to adapt and toughen up.
Should we stop taking ibuprofen and paracetamol?
No specialist is calling for a blanket ban on these drugs. Both ibuprofen and paracetamol remain key tools for easing pain and lowering fever. For people living with severe chronic pain, or those undergoing heavy treatments such as chemotherapy, they can be central to basic daily functioning.
What is changing is the view of how casually they are used, and especially how freely they are paired with antibiotics without any reflection on the combination.
Rethinking “just in case” dosing
Many individuals take these medications pre‑emptively: a couple of tablets “just in case” a cold gets worse, or to get through a long working day with a mild headache. In parallel, antibiotics are sometimes prescribed for viral infections, where they do nothing against the cause of the illness, or requested “just to be safe”.
When both tendencies meet, you get someone swallowing an antibiotic they do not need, plus a painkiller they might not absolutely require. For bacteria, that combination is a training ground.
| Common situation | Typical behaviour | Lower‑risk alternative |
|---|---|---|
| Mild viral cold | Antibiotic + paracetamol for several days | Paracetamol alone in the lowest effective dose; no antibiotic |
| Uncomplicated urinary infection | Antibiotic + high‑dose ibuprofen around the clock | Antibiotic + intermittent, on‑demand pain relief, reassessed daily |
| Post‑surgery soreness | Multiple painkillers plus preventive antibiotics for many days | Painkillers tailored to pain level, shortest possible antibiotic course |
What doctors and health systems can change
The Australian findings have reignited the push for “antibiotic stewardship” – a set of practices aimed at using these powerful drugs more carefully. Now, some experts argue that stewardship must widen to consider interactions with non‑antibiotic medicines, including over‑the‑counter painkillers.
That could mean doctors reviewing a patient’s full medication list before prescribing antibiotics and adjusting pain management plans accordingly. Pharmacies might also play a stronger role, asking people filling an antibiotic prescription what else they are taking and flagging frequent or high‑dose use of analgesics.
A new frontier in antibiotic stewardship is not just which antibiotic we use, but what other drugs sit beside it in the pill organiser.
What individuals can do today
For now, people can take a few simple steps:
- Use ibuprofen and paracetamol only when there is a clear need, and stop once symptoms ease.
- Stick to recommended doses and maximum daily limits printed on the pack.
- When prescribed an antibiotic, tell your doctor or pharmacist about every other medicine or supplement you take, including non‑prescription painkillers.
- Avoid pressuring clinicians for antibiotics when a viral infection is suspected.
Untangling some key terms
Two phrases appear a lot in this debate. They sound technical, but they shape policy and bedside decisions:
Antibiotic resistance refers to the ability of bacteria to survive and grow despite exposure to an antibiotic that would normally kill them or halt their growth. This often stems from genetic changes, which can be passed on to other bacteria.
Antimicrobial resistance is the broader concept, covering resistance not only to antibiotics but also to antivirals, antifungals and antiparasitic drugs. Ibuprofen and paracetamol sit outside these categories, yet they may still influence how bacteria respond to antibiotics.
Everyday scenarios that show the stakes
Imagine a care home where several residents develop urinary‑tract infections over winter. Each is prescribed an antibiotic, and almost all take regular ibuprofen for joint pain, plus paracetamol for fevers. Within months, the home starts seeing infections that no longer respond well to first‑line antibiotics. Staff suspect the usual culprit: overuse and cross‑spread of antibiotics. The new research suggests the constant background exposure to painkillers might also be tipping the balance.
Or think of a young adult with recurrent sinus infections. Each episode brings a prescription for antibiotics, and a familiar routine of paracetamol every four to six hours. After several years, lab tests show that the bacteria behind the infections have become resistant to several typical drugs. Trimmed‑down use of painkillers alongside tighter antibiotic prescribing earlier on might have changed that trajectory.
A changing view of “safe” combinations
Doctors used to focus mainly on acute toxic risks when combining medicines: liver damage from excessive paracetamol, kidney strain from ibuprofen, or interactions that raise blood pressure. The Australian study adds a more subtle, long‑term concern: combinations that push microbes, not human organs, into dangerous territory.
As more research arrives, guidance on when and how to pair antibiotics with over‑the‑counter painkillers is likely to shift. For now, the message is less about fear of a single tablet and more about respect for how frequently we reach for these drugs, and what else we swallow with them.